# OSR Health, Inc.: filings

OSRH · OTC · CIK 1840425 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/osrh.md) · [Financials](/companies/osrh/financials.md) · [Filings](/companies/osrh/filings.md) · [Insiders](/companies/osrh/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 68, 3 20, CORRESP 17, UPLOAD 16, 4 14, 10-Q 11, 425 9, DEF 14A 6, PRE 14A 6, S-1/A 6, 10-K 4, S-4/A 4, 424B3 3, 8-K/A 3, DRS/A 3, DRSLTR 3, EFFECT 3, NT 10-Q 3, SC 13G 3, SCHEDULE 13G/A 3, CERT 2, DRS 2, NT 10-K 2, S-1 2, SC 13G/A 2, SEC STAFF LETTER 2, 25-NSE 1, 424B4 1, 8-A12B 1, 8-A12B/A 1, ARS 1, DEFA14A 1, S-4 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 09:17 ET | [8-K](/filings/0001213900-26-110051.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-110051 |
| 2026-10-02 | 16:32 ET | [8-K](/filings/0001213900-26-106429.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-106429 |
| 2026-08-28 | 08:00 ET | [8-K](/filings/0001213900-26-094654.md) | 8.01 Other events | 0001213900-26-094654 |
| 2026-08-25 | 11:28 ET | [8-K](/filings/0001213900-26-093379.md) | 8.01 Other events | 0001213900-26-093379 |
| 2026-08-19 | 17:05 ET | [8-K](/filings/0001213900-26-091756.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091756 |
| 2026-08-14 | 15:08 ET | [10-Q](/filings/0001213900-26-089904.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089904 |
| 2026-08-10 | 11:09 ET | [8-K](/filings/0001213900-26-087087.md) | 5.07 Shareholder vote results | 0001213900-26-087087 |
| 2026-08-07 | 15:32 ET | [8-K](/filings/0001213900-26-086599.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-086599 |
| 2026-07-31 | 15:06 ET | [8-K](/filings/0001213900-26-083878.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-083878 |
| 2026-07-16 | 16:36 ET | [DEF 14A](/filings/0001213900-26-078706.md) | Proxy statement, period 2026-08-07 | 0001213900-26-078706 |
| 2026-06-17 | 12:27 ET | [8-K](/filings/0001213900-26-069524.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-069524 |
| 2026-06-11 | 13:35 ET | [8-K](/filings/0001213900-26-067732.md) | 8.01 Other events | 0001213900-26-067732 |
| 2026-06-02 | 13:16 ET | [8-K](/filings/0001213900-26-064037.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-064037 |
| 2026-05-26 | 17:00 ET | [DEF 14A](/filings/0001213900-26-061078.md) | Proxy statement, period 2026-06-18 | 0001213900-26-061078 |
| 2026-05-13 | 09:00 ET | [10-Q](/filings/0001213900-26-055492.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055492 |
| 2026-05-06 | 17:25 ET | [8-K/A](/filings/0001213900-26-052922.md) | 9.01 Financial statements and exhibits | 0001213900-26-052922 |
| 2026-04-30 | 13:06 ET | [8-K](/filings/0001213900-26-049967.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-049967 |
| 2026-04-22 | 17:27 ET | [8-K](/filings/0001213900-26-046711.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-046711 |
| 2026-04-09 | 09:15 ET | [8-K](/filings/0001213900-26-041768.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-041768 |
| 2026-04-03 | 06:15 ET | [8-K/A](/filings/0001213900-26-039691.md) | 9.01 Financial statements and exhibits | 0001213900-26-039691 |
| 2026-04-02 | 15:46 ET | [8-K](/filings/0001213900-26-039278.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-039278 |
| 2026-03-31 | 16:00 ET | [10-K](/filings/0001213900-26-037395.md) | Annual report, period 2025-12-31 | 0001213900-26-037395 |
| 2026-03-16 | 08:00 ET | [8-K](/filings/0001213900-26-027984.md) | 7.01 Regulation FD disclosure | 0001213900-26-027984 |
| 2026-03-10 | 08:01 ET | [8-K](/filings/0001213900-26-025428.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-025428 |
| 2026-01-27 | 09:26 ET | [8-K](/filings/0001213900-26-007987.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-007987 |
| 2026-01-14 | 09:27 ET | [8-K](/filings/0001213900-26-004199.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-004199 |
| 2025-11-25 | 10:56 ET | [8-K](/filings/0001213900-25-114496.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-114496 |
| 2025-11-12 | 14:02 ET | [10-Q](/filings/0001213900-25-109054.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109054 |
| 2025-10-16 | 11:10 ET | [8-K](/filings/0001213900-25-099393.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-099393 |
| 2025-09-23 | 08:40 ET | [8-K](/filings/0001213900-25-090340.md) | 5.07 Shareholder vote results | 0001213900-25-090340 |
| 2025-09-09 | 16:47 ET | [8-K](/filings/0001213900-25-086209.md) | 3.01 Delisting notice | 0001213900-25-086209 |
| 2025-09-09 | 17:39 ET | [8-K](/filings/0001213900-25-085670.md) | 8.01 Other events | 0001213900-25-085670 |
| 2025-08-29 | 07:00 ET | [DEF 14A](/filings/0001213900-25-082061.md) | Proxy statement, period 2025-09-17 | 0001213900-25-082061 |
| 2025-08-20 | 17:29 ET | [8-K](/filings/0001213900-25-079053.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-079053 |
| 2025-08-14 | 14:32 ET | [10-Q](/filings/0001213900-25-076461.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076461 |
| 2025-08-06 | 08:00 ET | [8-K](/filings/0001213900-25-072321.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-072321 |
| 2025-07-25 | 17:00 ET | [8-K](/filings/0001213900-25-067798.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-067798 |
| 2025-07-02 | 06:17 ET | [8-K](/filings/0001213900-25-060679.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-060679 |
| 2025-06-10 | 16:51 ET | [S-1/A](/filings/0001213900-25-053114.md) | Registration statement, amended | 0001213900-25-053114 |
| 2025-05-28 | 17:23 ET | [S-1](/filings/0001213900-25-048346.md) | Registration statement | 0001213900-25-048346 |
| 2025-05-20 | 16:00 ET | [10-Q](/filings/0001213900-25-045947.md) | Quarterly report, period 2025-03-31 | 0001213900-25-045947 |
| 2025-05-12 | 16:05 ET | [8-K](/filings/0001213900-25-042018.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-042018 |
| 2025-04-22 | 14:04 ET | [8-K/A](/filings/0001213900-25-034120.md) | 9.01 Financial statements and exhibits | 0001213900-25-034120 |
| 2025-04-22 | 14:01 ET | [10-K](/filings/0001213900-25-034116.md) | Annual report, period 2024-12-31 | 0001213900-25-034116 |
| 2025-03-25 | 07:00 ET | [8-K](/filings/0001013762-25-001833.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-25-001833 |
| 2025-02-28 | 18:27 ET | [8-K](/filings/0001213900-25-018204.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-018204 |
| 2025-02-21 | 16:10 ET | [8-K](/filings/0001213900-25-016100.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001213900-25-016100 |
| 2025-02-18 | 18:13 ET | [8-K](/filings/0001213900-25-014490.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-014490 |
| 2025-02-13 | 16:11 ET | [8-K](/filings/0001213900-25-013498.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-013498 |
| 2025-01-23 | 16:01 ET | [8-K](/filings/0001213900-25-005957.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-005957 |

Page 1 of 2. [Older](/companies/osrh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:31 ET. No prices; not investment advice.